Chronic Urticaria
Chronic Urticaria is a skin condition that causes persistent hives or welts, often resulting in itching and discomfort. It can last for six weeks or longer and may be triggered by various factors.
Chronic Urticaria: Briquilimab Study
We are studying the long-term safety and effectiveness of briquilimab in people with chronic urticaria. This trial includes participants from earlier studies to see how well the treatment works over time.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a woman who is pregnant or nursing?
- Do you have any active diseases that cause hives or swelling, like urticarial vasculitis or hereditary angioedema?
- Are you currently taking any medications that you are allergic to, such as certain antihistamines or antibodies?
- Have you participated in another clinical trial for an experimental therapy in the last 4 months?
- Are you a male who is heterosexually active and not using effective birth control?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Briquilimab
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Technische Universitaet Dresden
Klinik und Poliklinik für Dermatologie
Dresden, Germany
Medizinische Hochschule Hannover
Klinik für Dermatologie, Allergologie und Dermatologie
Laatzen, Germany
Universitaetsklinikum Schleswig-Holstein AöR
Institut für Entzündungsmedizin
Lübeck, Germany
Sponsor: Jasper Therapeutics Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.